Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1
OBR Daily - Our Oncology Focused E-News Service

Register for OBR daily



Warning: Missing argument 1 for showSidebarBanner(), called in /home2/don/public_html/sidebar_obrgreen.php on line 38 and defined in /home2/don/public_html/include/banners.php on line 243


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GERN $3.70 0.4500 +13.85%
GALE $2.07 0.2100 +11.29%
FATE $4.23 0.3800 +9.87%
PGNX $6.77 0.3500 +5.45%
NLNK $35.33 1.8100 +5.40%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARGS $8.50 -0.4100 -4.60%
EPZM $22.49 -1.0700 -4.54%
CLVS $48.60 -2.1900 -4.31%
CPXX $1.86 -0.0800 -4.12%
GALT $4.20 -0.1500 -3.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Thin Melanomas Cause Greater Number of Deaths

(Reuters Health) Nov 13, 2014 - More people are dying from melanomas thinner than a dime than from the thicker cancerous skin lesions long thought to be more dangerous, according to a new study from Queensland, Australia.
read article 



More Details on Possible Immunotherapy For Glioblastoma

(Medscape Medical News) Nov 14, 2014 - The mechanism of action of a promising experimental tumor-cell-derived vaccine for the treatment of glioblastomas has been revealed in a series of experiments conducted by American scientists.
read article (free registration required) 



High-Tech Goggles Help Surgeons Visualize Tumors

(Medscape Medical News) Nov 13, 2014 - Augmented reality, a Google Glass–like technology, could help surgeons prepare to resect tumors, report researchers here at the American College of Surgeons 2014 Clinical Congress.
read article (free registration required) 



Transplant Best For HIV Patients With Liver Cancer

(MedPage Today) Nov 13, 2014 - Liver transplant is the best treatment option for people with HIV and hepatocellular carcinoma, a researcher said here.
read article (free registration required) 



The Cancer Breakthrough With Big Implications

(TIME) Nov 13, 2014 - Once you’ve been diagnosed with cancer, you’re sent for a dizzying array of tests — but most of them are focused on you, as the living host of the tumors, and not on the malignant growths themselves.
read article 



In Its Bumpy Second Life, Geron Signs Top Drug Over to J&J

(Xconomy San Francisco) Nov 13, 2014 - As we saw this week with Dendreon, pioneers in the biomedical industry can end up with arrows in their back, bleeding to death. Geron has avoided that fate.
read article 



Puma Biotech Says Cancer Drug Fails Mid-Stage Study

(Reuters) Nov 13, 2014 - Puma Biotechnology Inc said its cancer drug failed as a primary treatment for breast cancer patients in a mid-stage study, sending its shares down 14 percent in extended trading.
read article 



Geron Could Get $935M in Blood Disorder Drug Deal

(BloombergBusinessweek/Associated Press) Nov 13, 2014 - Geron Corp. said Thursday it could get more than $900 million from a deal to develop its blood disorder drug imetelstat with a unit of Johnson & Johnson.
read article 



Cardinal Health Launches Online Tool To Help Retail Pharmacies Make It Easier For Patients to Compare Medicare Part D Plans

(Cardinal Health) Nov 13, 2014 - With the window for Medicare enrollment open from mid-October through Dec. 7, Cardinal Health recently launched a new online tool, developed by eHealth, Inc, that its retail pharmacy customers can use to help their patients compare Medicare Part D prescription drug plans.
read corporate press release 



AstraZeneca to Test Whether It Can Undo Effects of Its Own Heart Drug

(The Telegraph [UK]) Nov 13, 2014 - AstraZeneca is to run trials to determine whether it can reverse the effect of one of its drugs.
read article 



Valeant, Allergan Scuffle For Doctors

(Wall Street Journal) Nov 12, 2014 - As it fights to buy Botox maker Allergan Inc., Valeant Pharmaceuticals International Inc. is investing cash and time wooing the doctors it would need on its side after a takeover.
read article (paid subscription required) 



Growth of Digital Pharmaceutical Marketing Tactics Targeting Physicians Requires New Industry Standards, According to Penn Researchers

(Penn Medicine) Nov 12, 2014 - As pharmaceutical marketing activities in recent years have shifted away from traditional face-to-face methods towards more digital interactions, physicians may not be aware of the new ways they’re being marketed to, necessitating greater transparency and reporting.
read press release 



U.S. Prices Soaring For Some Generic Drugs, Experts Say

(U.S. News & World Report/HealthDay News) Nov 12, 2014 - Market forces are dramatically driving up the cost of some generic drugs, prompting U.S. investigations into the pricing of what should be cheap alternatives to brand-name medications.
read article 



AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods

(San Francisco Business Times) Nov 13, 2014 - Isis Pharmaceuticals, Inc. and AstraZeneca today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
read article 



Innocrin Pharmaceuticals and the Prostate Cancer Foundation (PCF) Join Forces For Innovative Phase 2 Clinical Study

(Yahoo! Finance) Nov 13, 2014 - Innocrin Pharmaceuticals, Inc. announces its participation in a multi-center Phase 2 clinical study of VT-464 in prostate cancer patients resistant to next-generation androgen receptor (AR) signaling inhibitors Zytiga® or Xtandi®.
read article 



Winthrop's Response to Criticism of Prostate Cancer Advertising

(Forbes) Nov 12, 2014 - I promised Winthrop University physicians a chance to respond to my earlier post.
read article 



WellPoint Email Glitch Puts Colonoscopy Test in the Subject Line

(Reuters) Nov 12, 2014 - Some WellPoint Inc customers got a surprise in their inbox this week: emails meant to remind them to get a specific preventative screening such as a colonoscopy or mammogram mistakenly included personal and health information in the subject line.
read article 



Strong Leaders Critical to Navigating Shifting Landscape in Oncology Care

(ACCC) Nov 12, 2014 - While the healthcare sector has many workforce issues, a group of experts recently examined one of the most critical workforce issues in cancer care—leadership.
read press release 



ASCO to Establish a Clinical Affairs Department to Provide Hands-On Assistance to Oncology Practices

(ASCO in Action) Nov 12, 2014 - ASCO is forming a Clinical Affairs department dedicated to providing services, education, and resources to support oncology practices.
read article 



When Diseases Collide: Less Than Half of Cancer Survivors Have Been Tested For HIV

(Fred Hutch News Service) Nov 13, 2014 - Despite known links between cancer and the virus that causes AIDS, less than half of cancer survivors in the U.S. younger than 65 have been tested for HIV, a first-ever government study finds.
read article 



Therapy for Myeloma Continues to Expand

(MedPage Today) Nov 12, 2014 - Recent improvement in myeloma outcomes will likely continue into the foreseeable future, as new classes of agents become available, including immunotherapy, according to a review of therapeutic progress.
read article (free registration required) 



MD Anderson’s David M. Gershenson, MD, Receives IGCS’s Award for Excellence in Gynecologic Oncology

(MD Anderson) Nov 10, 2014 - For his myriad clinical, organizational and scientific accomplishments in the field of gynecologic oncology and the health and well-being of women, David M. Gershenson, M.D. has been recognized with the International Gynecology Cancer Society’s (IGCS) Award of Excellence.
read press release 



Florida Cancer Specialists’ Integrative Oncology Program Researches Use of Acupuncture For Chemotherapy-Induced Peripheral Neuropathy

(FCS) Nov 13, 2014 - The Integrative Oncology Program (IOP) at Florida Cancer Specialists & Research Institute (FCS) blends traditional oncology treatments with evidence-based complementary therapies, such as acupuncture, nutrition and yoga, to reduce some of the side effects patients may experience with chemotherapy or radiation.
read press release 



Genetics to Drive Lung Cancer Treatments

(Marshfield News-Herald [Marshfield, WI]) Nov 12, 2014 - Lung cancer patients in central and northern Wisconsin might be eligible for more targeted treatment based on their genetic characteristics.
read article 



Clovis Oncology Says First Patient Enrolled in Phase 2 TIGER-1 Study

(StreetInsider) Nov 12, 2014 - Clovis Oncology, Inc. announced today that the Phase 2 portion of the seamless Phase 2/3 TIGER-1 (Third-Generation Inhibitor of Mutant EGFR in Lung Cancer) study has commenced with the dosing of the first patient at a U.S. study site.
read article